ClearPoint Neuro, Inc.
CLPTNASDAQHealthcare● Active
$12.89
$-1.43(-9.99%)
Market Cap$386565467
P/E Ratio—
52W High$30.1
52W Low$8.27
ClearPoint Neuro, Inc. (CLPT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CLPT · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.32
Est. -$0.28 · -14.3%
Revenue
$0.01B
Est. $0.01B · +1.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
CLPT reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 11, 2026 | -$0.27 | — | — | — | $0.01B | — |
| ▼ Q2 FY2026 | May 13, 2026 | -$0.28 | -$0.32 | -14.3% | $0.01B | $0.01B | +1.4% |
| ▼ Q1 FY2026 | Mar 17, 2026 | -$0.22 | -$0.27 | -22.7% | $0.01B | $0.01B | +3.5% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -$0.20 | -$0.21 | -5.0% | $0.01B | $0.01B | -14.8% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -$0.20 | -$0.21 | -5.0% | $0.01B | $0.01B | -6.0% |
| ▼ Q2 FY2025 | May 13, 2025 | -$0.15 | -$0.22 | -46.7% | $0.01B | $0.01B | -7.4% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -$0.15 | -$0.20 | -33.3% | $0.01B | $0.01B | -5.6% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -$0.17 | -$0.18 | -5.9% | $0.01B | $0.01B | +4.4% |
Q3 FY2026
Aug 11, 2026
EPS Actual
—
EPS Est.
-$0.27
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Miss
EPS Actual
-$0.32
EPS Est.
-$0.28
EPS Surpr.
-14.3%
Revenue
$0.01B
Q1 FY2026
Mar 17, 2026Miss
EPS Actual
-$0.27
EPS Est.
-$0.22
EPS Surpr.
-22.7%
Revenue
$0.01B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
-$0.21
EPS Est.
-$0.20
EPS Surpr.
-5.0%
Revenue
$0.01B
Q3 FY2025
Aug 12, 2025Miss
EPS Actual
-$0.21
EPS Est.
-$0.20
EPS Surpr.
-5.0%
Revenue
$0.01B
Q2 FY2025
May 13, 2025Miss
EPS Actual
-$0.22
EPS Est.
-$0.15
EPS Surpr.
-46.7%
Revenue
$0.01B
Q1 FY2025
Feb 26, 2025Miss
EPS Actual
-$0.20
EPS Est.
-$0.15
EPS Surpr.
-33.3%
Revenue
$0.01B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
-$0.18
EPS Est.
-$0.17
EPS Surpr.
-5.9%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.21 | $-0.20 | $-0.19 | 1 |
| Q3 FY2027 | $-0.22 | $-0.21 | $-0.20 | 1 |
| Q2 FY2027 | $-0.23 | $-0.23 | $-0.22 | 1 |
| Q1 FY2027 | $-0.24 | $-0.23 | $-0.23 | 1 |
| Q4 FY2026 | $-0.25 | $-0.24 | $-0.24 | 1 |
| Q3 FY2026 | $-0.27 | $-0.26 | $-0.25 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 13, 2026 | -14.3% | $12.64 | $12.19 | -3.56% |
| ▼ Q1 FY2026 | Mar 17, 2026 | -22.7% | $11.03 | $11.16 | +1.18% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -5.0% | $16.98 | $18.23 | +7.36% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -5.0% | $10.60 | $10.54 | -0.57% |
| ▼ Q2 FY2025 | May 13, 2025 | -46.7% | $13.64 | $14.20 | +4.11% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -33.3% | $16.72 | $17.22 | +2.99% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -5.9% | $13.38 | $13.42 | +0.30% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +15.8% | $6.67 | $6.44 | -3.45% |
Q2 FY2026-3.56%
Report Date
May 13, 2026
EPS Beat/Miss
-14.3%
Price Before
$12.64
Price After
$12.19
Q1 FY2026+1.18%
Report Date
Mar 17, 2026
EPS Beat/Miss
-22.7%
Price Before
$11.03
Price After
$11.16
Q4 FY2025+7.36%
Report Date
Nov 6, 2025
EPS Beat/Miss
-5.0%
Price Before
$16.98
Price After
$18.23
Q3 FY2025-0.57%
Report Date
Aug 12, 2025
EPS Beat/Miss
-5.0%
Price Before
$10.60
Price After
$10.54
Q2 FY2025+4.11%
Report Date
May 13, 2025
EPS Beat/Miss
-46.7%
Price Before
$13.64
Price After
$14.20
Q1 FY2025+2.99%
Report Date
Feb 26, 2025
EPS Beat/Miss
-33.3%
Price Before
$16.72
Price After
$17.22
Q4 FY2024+0.30%
Report Date
Nov 7, 2024
EPS Beat/Miss
-5.9%
Price Before
$13.38
Price After
$13.42
Q3 FY2024-3.45%
Report Date
Aug 7, 2024
EPS Beat/Miss
+15.8%
Price Before
$6.67
Price After
$6.44
Avg Beat Reaction-3.45%
Avg Miss Reaction+1.69%
Beat Rate1 / 8 quarters
Largest Move+7.36% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CLPT ends December
ClearPoint Neuro, Inc. (CLPT) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.32 — missing the analyst consensus of $-0.28 by -14.3%. The next CLPT earnings date is expected around September 1, 2026.
Each quarter, investors track CLPT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CLPT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CLPT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CLPT earnings · 5 questionsClearPoint Neuro, Inc.'s next earnings report is expected around September 1, 2026. CLPT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CLPT historically reports after market close (AMC).
CLPT earnings datewhen is CLPT earningsCLPT next earnings datewhen does CLPT report earningsCLPT earnings calendar
▸ Source: FMP · ClearPoint Neuro, Inc. SEC filings · US GAAP · ClearPoint Neuro, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026